Weight-loss medications
Wegovy appears to reduce how much alcohol people drink. How it affects cravings and hangovers, and what drinking safely on it looks like.
Weight-loss medications
Foundayo (orforglipron) is a daily GLP-1 pill for weight loss (11.2%) with no fasting requirements. MHRA approved for UK use on August 10th 2026.
Weight-loss medications
ATTAIN-MAINTAIN trial: people who switched from Mounjaro or Wegovy injections to Foundayo kept 75-79% of their weight loss. Now approved in the UK.
Weight-loss medications
Tingling on Wegovy affected 22.9% of people on 7.2 mg and 6.0% on 2.4 mg in the STEP UP trial. Why it happens, and when to speak to your prescriber.
Weight-loss medications
Ozempic is only available on the NHS for type 2 diabetes, not weight loss. Wegovy and Mounjaro are the UK's licensed weight-loss injections.
Weight-loss medications
You can't get the Wegovy pill on the NHS yet. It's UK-approved, but NHS funding needs a NICE decision, most likely in 2028.
Weight-loss medications
Use our free GLP-1 progress checker to see if you're on track with your weight loss and habits while taking Mounjaro, Wegovy, or the Wegovy pill.
Weight-loss medications
You can take the Wegovy pill with levothyroxine, but not together. Take the pill, wait 30 minutes, then levothyroxine, or move it to bedtime.
Weight-loss medications
The Wegovy pill, oral semaglutide, produces around 13.6% average weight loss, similar to the 2.4 mg injection but less than Mounjaro or the 7.2 mg dose.
Weight-loss medications
Mounjaro alternatives UK: Compare Wegovy, the Wegovy pill, Saxenda, and Orlistat. Includes clinical trial data, side effects, and pricing.